A case of inappropriate ICD shock causing cardiac arrest

Slides:



Advertisements
Similar presentations
Lab/ECG/Xray Rounds The EM Resident Provisionally Known as Sean Caine CCFP-EM March 5, 2008.
Advertisements

Subcutaneous Implantable Cardioverter Defibrillator (S-ICD)
CARDIAC EMERGENCIES. Anatomy of the Heart Muscular organ (fist size) Muscular organ (fist size) Functions like a pump Functions like a pump Protected.
Patients with suspected syncope should be investigated by cardiologists Dr NR Stout.
©2014 MFMER | slide-1 Cardiac Screening in Athletes A Brief Review Sara Filmalter, MD Mayo Clinic Florida Jacksonville Sports Medicine Symposium April.
Sudden Cardiac Death in Young Athletes Yann Ping Pan, MD Ruey-Kang Chang, MD, MPH.
Hypertrophic Cardiomyopathy Guidelines Summary from the: ACC/ESC Clinical Expert Consensus Statement on Hypertrophic Cardiomyopathy Maron BJ, et al. J.
Brugada Syndrome Carly Thompson MD CCFP EM Resident July 31, 2008.
Implantable Cardioverter Defibrillators to Prevent Sudden Cardiac Death: Background Frederick A. Masoudi, MD, MSPH Associate Professor of Medicine (Cardiology)
IMPANTABLE CARDIOVERTER DEFIBRILLATORS (ICDs) Janet McComb Freeman Hospital Newcastle upon Tyne.
: Epidemiology of Morbidity and Mortality from Particles and Co-Pollutants: Respiratory, Cardiovascular, and Cancer Douglas W. Dockery Harvard School of.
SYNCOPE. 42 yo man comes to the ER with syncope He was standing in line waiting to renew his driver’s license Felt tired, nauseated, few seconds later.
1 Case 2 Witnessed VF: Treated With an AED and CPR © 2001 American Heart Association.
Arrhythmias Medical Student Teaching Tuesday 24 th January 2012 Dr Karen Jones, SpR Emergency Medicine.
Pacemaker Follow-up Alpay Çeliker MD. Hacettepe University Department of Pediatric Cardiology 3rd International Summer School on Cardiac Arrhythmias, 9-12.
Cost-Conscious Care Presentation Follow-up Chest X-Ray in Patients Admitted for Community Acquired Pneumonia Huy Tran, PGY-2 12/12/2013.
Clinical Correlations The NYU Internal Medicine Blog A Daily Dose of Medicine
Sudden Cardiac Death; Invasive Evaluation Alpay Çeliker MD Hacettepe University Department of Pediatric Cardiology Ankara, Türkiye.
Rhythm Strips Jessica Wagner UMSON. EKG Grid.
EP Show – Aug 2003 ICDs – Secondary prevention The EP Show: Which ICD for which patient? Part 1: Secondary prevention Eric Prystowsky MD Director, Clinical.
An Electrical Storm 9 th May 2014 U Buckley, D Eaton, J Galvin, T Keelan Mater Misericordiae Hospital, Dublin.
Patient work up – the arrhythmia nurse perspective Hilary Bugden RN, MSc Papworth Hospital Cambridge.
© 2008, American Heart Association. All rights reserved. AHA/ACC/HRS Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying.
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Recent Advances in Cardiopulmonary Resuscitation:
Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: AACVPR/ACC/AHA 2007 Performance Measures on Cardiac.
Date of download: 5/31/2016 Copyright © The American College of Cardiology. All rights reserved. From: Spectrum and prognostic significance of arrhythmias.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Inappropriate Implantable Cardioverter-Defibrillator.
Date of download: 6/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: Long-Term Follow-Up of a Pediatric Cohort With Short.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Pregnancy in Patients With Pre-Existing Cardiomyopathies.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACC/AHA/ESC 2006 Guidelines for Management of Patients.
Emergency Medicine Junior Teaching Programme Aberdeen Royal Infirmary Adult Syncope Evaluation in the Emergency Department Jamie Cooper Teaching 4 th March.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Reduction in Ventricular Tachyarrhythmias With Statins.
Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS.
Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: Implantable Cardiac Defibrillator Lead Failure and.
Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010.
Date of download: 6/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Significance of Non-Type 1 Anterior Early Repolarization.
Date of download: 7/6/2016 Copyright © The American College of Cardiology. All rights reserved. From: Hypertrophic Cardiomyopathy in Adulthood Associated.
Date of download: 7/6/2016 Copyright © The American College of Cardiology. All rights reserved. From: Incidence and Predictors of Implantable Cardioverter-Defibrillator.
Date of download: 7/7/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACC/AHA guidelines for the management of patients.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Safety and Efficacy of the Totally Subcutaneous Implantable.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Remote Monitoring of Implantable Cardioverter-Defibrillators:
Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Wearable Cardioverter-Defibrillator Use in Patients.
Implantable Cardioverter Defibrillators & End of Life Anna Wilson Cardiac Physiologist Waikato Hospital.
My Best Radial Case of the Past Year ... And what I learned from it
Stepwise approach to assessing cardiac patient risk for noncardiac surgery. (Reproduced, with permission, from Fleisher LA et al. ACC/AHA 2007 Guidelines.
Stepwise approach to assessing cardiac patient risk for noncardiac surgery. (Reproduced, with permission, from Fleisher LA et al. ACC/AHA 2007 Guidelines.
Sudden Cardiac Death in Young Athletes
Athletes and Sudden Cardiac Death
Risk Stratification of Chest Pain: Best Practices
Patient Decision Aid: Sharing Goals for ICU care
Cardiac Screening in Athletes A Brief Review
Echocardiograms in syncope work-up
C. ACC/AHA/ESC guidelines Role of anticoagulant therapy in AF
Tom F. Brouwer et al. JACEP 2016;2:89-96
José L. Morales et al. JACEP 2017;j.jacep
Heart Rhythm Management Case Study Submission & Template
Figure 6 Risk stratification in hypertrophic cardiomyopathy (HCM)
Tom F. Brouwer et al. JACEP 2016;2:
Belinda Gray et al. JCHF 2013;1:
David F. Katz et al. JACEP 2016;j.jacep
Sudden Cardiac Arrest in Intercollegiate Athletics
Federico Migliore et al. JACEP 2016;2:
Prabhat Kumar et al. JACEP 2016;j.jacep
David F. Katz et al. JACEP 2017;3:20-28
Ayman A. Hussein et al. JACEP 2017;3:1-9
Matthew M. Zipse et al. JACEP 2015;1:94-102
Jordan S. Leyton-Mange et al. JACEP 2017;j.jacep
Jeffrey B. Geske et al. JCHF 2018;j.jchf
New changes for CPR 2006.
Orthostatic increase in defibrillation threshold leading to defibrillation failure and prolonged cardiac arrest in a sitting position: Lessons from a.
Presentation transcript:

A case of inappropriate ICD shock causing cardiac arrest Dr Darragh Moran, Dr Niall Mahon

2003 ED MMUH 16 year old male Chest discomfort Abnormal ECG Normal coronaries

IVDd of 22mm No LVOT gradient noted Satisfactory TMET Rx betablockade Normal 24 holter Episodic left-sided chest discomfort persisted No family history of SCD

May 2007, aged 20 ED MMUH – collapse following game of soccer

At that time his ventricular septum had significantly increased in diameter, with diastolic measurements of 35-37mm. There was also noted to be an obstructive element to his myocardial hypertrophy on this occasion, with near cavity obliteration in systole.

At that time his ventricular septum had significantly increased in diameter, with diastolic measurements of 35-37mm. There was also noted to be an obstructive element to his myocardial hypertrophy on this occasion, with near cavity obliteration in systole.

At that time his ventricular septum had significantly increased in diameter, with diastolic measurements of 35-37mm. There was also noted to be an obstructive element to his myocardial hypertrophy on this occasion, with near cavity obliteration in systole.

No arrhythmia seen during inpatient monitoring TMET – drop in blood pressure at peak exertion

ACC/ESC expert consensus HCM One of the above features suggests ICD requirement ~1% annual risk of SCD in several series No genotype risk stratification as yet, although there is data to suggest MYH7 genotype is associated with a more severe phenotype with a younger age of onset, more LVH, and more sudden death than mutations in the MYBPC3 gene. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents and the European Society of Cardiology Committee for practice guidelines. J Am Coll Cardiol 2003;42:1687–713.

18 days later – ED MMUH OHCA whilst cycling Prolonged CPR, external DCCV for VF at scene GCS 3, intubation and ventilation with inotropic support GCS 11 day 2, GCS 15 day 4 Aspiration pnemonia Post-traumatic amnesia, poor concentration, attention deficit

ICD interrogation: inappropriate ICD shock for T-wave oversensing whilst in sinus tachycardia This inappropriate shock resulted in VF which was appropriately sensed by the device, however six 25J ICD shocks, as well as anti-tachycardia pacing during charging, failed to adequately defibrillate. Ultimately he required external DC cardioversion of 200J of biphasic energy, to restore sinus rhythm.

RV lead repositioning DFT testing – failed 25J and 35J shocks requiring 200J external rescue shock

Because of this high defibrillation thresold (DFT), a transvenous coil was inserted into the superior vena cava (SVC). Different vectors were employed via device programming, however the lowest defibrillation thresold recorded was 35J, which was inappropriately high and did not afford an adequate safety margin.

A decision was made for insertion of a subcutaneous array to reduce the defibrillation threshold. The transvenous lead was extracted. Following this, defibrillation was succesful at 25J on two occasions and unsuccesful once, requiring a 35J rescue shock.

Defibrillation testing was repeated 1 week later Defibrillation testing was repeated 1 week later. No further T wave oversensing was detected during this interrogation. VF was appropriately sensed by the ICD, both a 20J and 25J shock were unsuccesful, with a 30J rescue shock being required to restore sinus rhythm. The patient was discharged home in the days that followed.

2/12 later, patient returned to hospital as SC array had dislodged whilst swimming

Cardiac theatre was booked for the insertion of an epicardial patch, which was succesfully carried out and a defbrillation threshold of 25J was obtained, with a RV coil to epicardial patch vector. The VF detection rate was increased to 215bpm.

2 years of uneventful follow-up 2009 – threatened pocket erosion of device Deep submuscular repositioning Device check April 2010, high impedance values, >200J, sensitivity of 0.6mV Admitted for revision and testing of leads and epicardial patch

. The procedure was complicated by the finding of a subtotal occlusion of the SVC. Percutaneous venoplasty was attempted, however vessel patency was not satisfactorily restored. The epicardial patch impedance was found to be >200J, and his RV lead impedance was within normal limits. The defibrillation vector was changed to RV to can, excluding the failed epicardial patch. No defibrillation testing was done at that time.

3/7 later patient returned for DFT testing 1st 35J shock was unsuccessful, 2nd successfully restored SR Long discussion with patient regarding risks and benefits of further intervention Discharged home, albeit with unsatisfactory DFT

Pain and swelling around device insertion site Few months later… Pain and swelling around device insertion site Chronic pocket infection Device explanted He was diagnosed with a chronic pocket infection, most likely the result of repeated, time-consuming revisions, thereby increasing his infection risk. His device was explanted, and his RV lead was left in situ as severe fibrosis resulted in failure to extract this lead. His RV lead was cut as short as possible during the procedure. The epicardial patch and lead was also left in situ

He was diagnosed with a chronic pocket infection, most likely the result of repeated, time-consuming revisions, thereby increasing his infection risk. His device was explanted, and his RV lead was left in situ as severe fibrosis resulted in failure to extract this lead. His RV lead was cut as short as possible during the procedure. The epicardial patch and lead was also left in situ

7 years of device complications No ventricular events in that time High risk of SCD SC implantable defibrillator offered AEDs located at workplace and also at the gym patient attends to reduce risk of SCD No further symptoms/adverse events to date